Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimation of exponential rates in non-homogeneous populations using the EAIR estimator.

Journal of biopharmaceutical statistics·2026
Same author

The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis.

Kidney international·2025
Same author

Testing One Primary and Two Secondary Endpoints in a Two-Stage Group Sequential Trial With Extensions.

Statistics in medicine·2025
Same author

Estimand Framework and Statistical Considerations for Integrated Analysis of Clinical Trial Safety Data.

Therapeutic innovation & regulatory science·2024
Same author

Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data.

Statistics in medicine·2024
Same author

Multiplicity adjustments for the Dunnett procedure under heterokcedasticity.

Biometrical journal. Biometrische Zeitschrift·2023

Related Experiment Video

Updated: Jun 2, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Multistage and mixture parallel gatekeeping procedures in clinical trials.

Alex Dmitrienko1, George Kordzakhia, Ajit C Tamhane

  • 1Eli Lilly and Company, Indianapolis, Indiana 46285, USA. dmitrienko_alex@lilly.com

Journal of Biopharmaceutical Statistics
|April 26, 2011
PubMed
Summary

This study enhances gatekeeping procedures for clinical trials, improving statistical power in hypothesis testing. New methods offer greater efficiency than existing multistage approaches for hierarchical objectives.

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Related Experiment Videos

Last Updated: Jun 2, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Inference

Background:

  • Multiplicity problems in clinical trials with hierarchical objectives require specialized statistical procedures.
  • Existing multistage parallel gatekeeping procedures offer a general framework for hypothesis testing.
  • Optimizing power while controlling Type I error is crucial in clinical trial analysis.

Purpose of the Study:

  • To investigate two novel classes of parallel gatekeeping procedures for clinical trials.
  • To develop more powerful gatekeeping procedures than existing multistage methods.
  • To explore methods for enhancing the power of multistage gatekeeping procedures.

Main Methods:

  • Utilizing the mixture method and closure principle for constructing parallel gatekeeping procedures.
  • Applying alpha-exhaustive tests to component procedures within multistage gatekeeping frameworks.
  • Extending developed methods to handle multiple families of hypotheses.

Main Results:

  • A class of parallel gatekeeping procedures derived using the closure principle demonstrates superior power compared to multistage procedures.
  • Employing alpha-exhaustive tests significantly improves the power of multistage gatekeeping procedures.
  • The proposed methods are applicable to both two-family and multiple-family hypothesis testing scenarios.

Conclusions:

  • The developed parallel gatekeeping procedures offer enhanced statistical power for clinical trials.
  • Improvements in gatekeeping procedures contribute to more efficient and effective clinical trial designs.
  • These advancements provide valuable tools for statistical analysis in hierarchical clinical trial settings.